21 articles for L Su
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery and Structure-Activity Relationships of the Neoseptins: A New Class of Toll-like Receptor-4 (TLR4) Agonists.

The Scripps Research Institute
Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent.

Shandong University
Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.

TBA
Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.

Shandong University
Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.

Shandong University
Pyrrolo[2,3-c]azepine derivatives: a new class of potent protein tyrosine phosphatase 1B inhibitors.

Sun Yat-Sen University
Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.

Shandong University
Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors.

Shandong University
Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.

Shandong University
Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation.

Peking University
Discovery of novel and selective farnesoid X receptor antagonists through structure-based virtual screening, preliminary structure-activity relationship study, and biological evaluation.

Peking University
Long Residence Time at the Vasopressin V

Xuzhou Medical University
Benzodiazepine Derivatives as Potent Vasopressin V

Xuzhou Medical University
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease.

Peking University
Finding the mechanism of esterase D activation by a small molecule.

Shandong University
Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration.

Novartis Institutes For Biomedical Research
Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors.

Qingdao University
Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.

University of Pittsburgh
Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay.

Zhejiang University
Swinhoeisterols from the South China Sea Sponge Theonella swinhoei.

Second Military Medical University
KAT6 Inhibitors

Beigene Switzerland